Stock IINN INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Inspira Technologies Oxy B.H.N. Ltd.

Equities

IINN

IL0011715781

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
1.89 USD +0.53% Intraday chart for Inspira Technologies Oxy B.H.N. Ltd. +5.00% +78.30%
04-17 Inspira Technologies OXY B.H.N. Ltd Signs Collaboration Term Sheet with the Beilinson Hospital in Israel for the Evaluation of Its Proprietary INSPIRA ART100 device in Organ Transplant Procedures CI
04-16 Inspira, Beilinson Hospital Collaborate on Organ Transplant Device Evaluation MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Inspira Technologies OXY B.H.N. Ltd Signs Collaboration Term Sheet with the Beilinson Hospital in Israel for the Evaluation of Its Proprietary INSPIRA ART100 device in Organ Transplant Procedures
CI
Inspira, Beilinson Hospital Collaborate on Organ Transplant Device Evaluation
MT
Inspira?? and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth Causes Bloodstream Infections
CI
Inspira? Technologies Oxy B.H.N. Ltd. Announces Program to Pioneer the Applicable Use of the INSPIRA? ART100 Device for an Artificial Womb
CI
Inspira Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
AQ
Inspira Technologies Reports Full Year 2023 Financial Results
AQ
Inspira Technologies Oxy B.H.N. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Inspira Technologies OXY B.H.N. Ltd. Announces AMAR Regulatory Submission of the INSPIRA? ART100, to Enter the Southeast Asia and South American Markets
CI
Inspira Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
CI
INSPIRA TECHNOLOGIES OXY B H N : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K
PU
INSPIRA TECHNOLOGIES OXY B H N : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K
PU
Inspira Technologies Oxy B.H.N. Ltd. Plans to Report the Primary Results for A Core Blood Oxygenation Technology Within Days
CI
Inspira Announces Breakthrough Update, Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements
AQ
Inspira to Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone
AQ
Inspira Technologies Oxy B.H.N. Ltd. Announces Approval from the U.S. Food & Drug Administration for its INSPIRA ART100 in the First Half of 2024
CI
Inspira Technologies OXY B.H.N. Ltd. Introduces High-End Platform for Bio-Mimicking Blood parameters for Development and Testing of Core Technologies
CI
Inspira Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
AQ
Sector Update: Health Care Stocks Gain Late Afternoon
MT
Sector Update: Health Care Stocks Rise in Afternoon Trading
MT
Sector Update: Health Care
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IINN Stock
  4. News Inspira Technologies Oxy B.H.N. Ltd.